BCM
Bayesian Capital Management’s Gilead Sciences GILD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-51,100
| Closed | -$5.73M | – | 670 |
|
|
2025
Q1 | $5.73M | Buy |
51,100
+29,500
| +137% | +$3.31M | 0.95% | 11 |
|
|
2024
Q4 | $2M | Buy |
+21,600
| New | +$2M | 0.24% | 125 |
|
|
2024
Q2 | – | Sell |
-16,200
| Closed | -$1.19M | – | 883 |
|
|
2024
Q1 | $1.19M | Buy |
+16,200
| New | +$1.19M | 0.11% | 255 |
|
|
2023
Q4 | – | Sell |
-61,100
| Closed | -$4.58M | – | 856 |
|
|
2023
Q3 | $4.58M | Buy |
+61,100
| New | +$4.58M | 0.52% | 41 |
|
|
2023
Q2 | – | Sell |
-28,300
| Closed | -$2.35M | – | 892 |
|
|
2023
Q1 | $2.35M | Buy |
+28,300
| New | +$2.35M | 0.29% | 95 |
|
|
2022
Q4 | – | Sell |
-9,400
| Closed | -$580K | – | 860 |
|
|
2022
Q3 | $580K | Buy |
+9,400
| New | +$580K | 0.12% | 244 |
|
|
2021
Q4 | – | Sell |
-35,400
| Closed | -$2.47M | – | 434 |
|
|
2021
Q3 | $2.47M | Buy |
+35,400
| New | +$2.47M | 0.72% | 19 |
|
|
2021
Q1 | – | Sell |
-54,100
| Closed | -$3.15M | – | 594 |
|
|
2020
Q4 | $3.15M | Buy |
54,100
+26,700
| +97% | +$1.56M | 0.82% | 17 |
|
|
2020
Q3 | $1.73M | Buy |
+27,400
| New | +$1.73M | 0.42% | 54 |
|
|
2019
Q4 | – | Sell |
-12,689
| Closed | -$804K | – | 659 |
|
|
2019
Q3 | $804K | Buy |
+12,689
| New | +$804K | 0.15% | 189 |
|
|
2017
Q4 | – | Sell |
-15,300
| Closed | -$1.24M | – | 608 |
|
|
2017
Q3 | $1.24M | Buy |
+15,300
| New | +$1.24M | 0.3% | 101 |
|
|
2016
Q2 | – | Sell |
-3,168
| Closed | -$291K | – | 448 |
|
|
2016
Q1 | $291K | Buy |
+3,168
| New | +$291K | 0.27% | 159 |
|